Compare Mounjaro vs Wegovy: Which Suits You Better?
Mounjaro vs Wegovy Weight Loss: Key Mechanism Differences
Understanding how Mounjaro and Wegovy work differently helps inform treatment decisions when comparing these weight management options. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors, offering a dual-action approach that may influence blood sugar regulation alongside appetite control. Both prescription-only medicines require clinical assessment through our regulated pharmacy process.
The practical implications of these mechanism differences become clearer during treatment. Wegovy's single-target approach has been extensively studied through the STEP trial programme, providing robust evidence for its weight management effects. Mounjaro's dual-receptor targeting represents a newer approach, though both treatments require commitment to reduced-calorie diet and increased physical activity for optimal results. Your prescriber at EverydayMeds can evaluate which mechanism better suits your metabolic profile and weight management goals.
Wegovy vs Mounjaro Pricing: UK Online Comparison
Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout to reach these final prices, while returning customers use code DOSE25. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, provide convenient multi-week supply options. Mounjaro pricing varies but both treatments are available through the same streamlined ordering process.
Bundle options offer supply security rather than cost savings, ensuring continuity during your weight management journey. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99 and covers three dose escalation stages, while our Ultimate Stability Trio provides three months of maintenance supply for £649.99. Both Wegovy and Mounjaro require identical prescription processes through our GPhC-registered pharmacy, with the same clinical assessment and prescriber review standards regardless of which treatment you choose.
Clinical Evidence: Mounjaro vs Wegovy Weight Loss Trials
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 study (Wilding et al., NEJM, 2021). The STEP programme demonstrated sustained weight management over two years, with STEP 5 showing maintained clinically studied weight loss. These results occurred within controlled trial conditions with structured dietary and exercise support.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, though direct comparison between trial results isn't appropriate due to different study designs, patient populations, and endpoints. Both treatments showed weight regain when discontinued, with STEP 1 extension data indicating patients regained approximately two-thirds of lost weight within one year of stopping Wegovy. This emphasises that weight management represents a long-term commitment regardless of which treatment option you choose.
How Wegovy Works for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking incretin hormones that naturally regulate appetite and food intake. When injected once weekly using the FlexTouch pen device, semaglutide binds to GLP-1 receptors in brain appetite centres, potentially reducing food cravings and promoting feelings of fullness after smaller meals. This mechanism may help patients naturally consume fewer calories without the psychological stress of severe dietary restriction. The medication works gradually, requiring dose escalation over 16 weeks to reach the 2.4mg maintenance dose. Wegovy must be prescribed alongside a reduced-calorie diet and increased physical activity, as it supports rather than replaces healthy lifestyle changes.
EverydayMeds Ordering Process: Mounjaro vs Wegovy
Our streamlined ordering process applies identically whether you're considering Mounjaro or Wegovy for weight management. Complete our 3-minute online clinical assessment covering medical history, current medications, and weight management goals, then submit for prescriber review. Our qualified prescribers typically complete reviews within 3 working days (or 24 hours with express service), evaluating which treatment option suits your individual circumstances. Once approved, we dispatch your prescribed medication via next-day cold-chain delivery, maintaining the 2-8°C temperature requirement throughout transit. This regulated process ensures you receive genuine pharmaceutical products through our GPhC-registered pharmacy (#9012878).
Storage and Practical Considerations: Key Differences
Storage requirements present one practical difference when comparing Mounjaro vs Wegovy for UK patients. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, offering superior travel flexibility compared to Mounjaro's 21-day room temperature limit. Both require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability proves advantageous for business travel or holiday periods. The FlexTouch pen device used for Wegovy injections provides precise dose delivery with minimal injection technique training required. Dose escalation follows a mandatory schedule over 16 weeks, progressing from 0.25mg through to 2.4mg maintenance dosing regardless of individual tolerance levels.
UK Regulatory Status: Mounjaro vs Wegovy Comparison
Both Mounjaro and Wegovy hold MHRA licensing for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Wegovy additionally has NICE recommendation (TA875) for use with specialist weight management support, providing NHS pathway recognition that may influence insurance or occupational health considerations. Both treatments carry Black Triangle status (▼), indicating additional monitoring requirements for newly licensed medicines. This regulatory framework ensures both options meet identical safety and efficacy standards for UK patients.
The MHRA approved a higher 7.2mg Wegovy dose on 6 January 2026, though this isn't yet available through EverydayMeds while we await supply chain establishment. Current 2.4mg maintenance dosing remains the standard for both new and continuing patients. Your prescriber will determine appropriate treatment duration based on individual response and tolerance, with both Wegovy and Mounjaro requiring ongoing medical supervision throughout treatment.
Make Your Choice: Order Mounjaro or Wegovy Today
Both Wegovy and Mounjaro are available from EverydayMeds, with your prescriber helping determine which treatment aligns with your weight management goals and medical history. New customers can use discount code FIRST40 at checkout, while returning customers apply DOSE25 to access our competitive pricing structure. Our regulated ordering process ensures you receive authentic pharmaceutical products with proper clinical oversight, whether you choose Wegovy's established GLP-1 approach or Mounjaro's dual-receptor mechanism. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step towards medically-supervised weight management. Remember that both treatments work best alongside sustained lifestyle changes, and our clinical team remains available to support your journey throughout treatment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
